REV1: A novel biomarker and potential therapeutic target for various cancers
Background: REV1 is a member of the translesion synthesis DNA polymerase Y family. It is an essential player in a variety of DNA replication activities, and perform major roles in the production of both spontaneous and DNA damage-induced mutations. This study aimed to explore the role of REV1 as a p...
Main Authors: | Ning Zhu, Yingxin Zhao, Mi Mi, Yier Lu, Yinuo Tan, Xuefeng Fang, Shanshan Weng, Ying Yuan |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-09-01
|
Series: | Frontiers in Genetics |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fgene.2022.997970/full |
Similar Items
-
REV1 Inhibition Enhances Radioresistance and Autophagy
by: Kanayo E. Ikeh, et al.
Published: (2021-10-01) -
The Catalytic Activity of Human REV1 on Undamaged and Damaged DNA
by: Anastasia D. Stolyarenko, et al.
Published: (2024-04-01) -
Protein–Protein Interactions in Translesion Synthesis
by: Radha Charan Dash, et al.
Published: (2021-09-01) -
Global burden of tracheal, bronchus, and lung cancer attributable to occupational carcinogens in 204 countries and territories, from 1990 to 2019: results from the global burden of disease study 2019
by: Yan Zhang, et al.
Published: (2023-12-01) -
Mechanisms and Regulation of DNA-Protein Crosslink Repair During DNA Replication by SPRTN Protease
by: Megan Perry, et al.
Published: (2022-06-01)